Are staging investigations being overused in patients with low and intermediate risk prostate cancer?-Reference-Cited by-同舟云学术

Are staging investigations being overused in patients with low and intermediate risk prostate cancer?

Published:2014-09-04 Issue:1 Volume:59 Page:77-81
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:Journal of Medical Imaging and Radiation Oncology

Author:

Kim Laurence¹,Min Myo¹,Roos Daniel¹²,Nguyen Luom¹,Yeoh Eric¹²

Affiliation:

1. Department of Radiation Oncology; Royal Adelaide Hospital; South Australia Australia

2. School of Medicine; University of Adelaide; Adelaide South Australia Australia

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference24 articles.

1. Mohler JL Armstrong AJ Bahnson RR NCCN Guidelines http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

2. Prostate cancer for Australia (ICD10 C61) Australian Institute of Health and Welfare (AIHW) 2012

3. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era;D'Amico;J Urol,2001

4. The EviQ Guidelines 2011 https://www.eviq.org.au/Category/tabid/65/categoryid/185/Default.aspx

5. Carroll P Albertsen PC Greene K PSA testing for the pretreatment staging and posttreatment management of prostate cancer: 2013 revision of 2009 best practice statement AUA Guidelines https://www.auanet.org/common/pdf/education/clinical-guidance/Prostate-Specific-Antigen.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OR Practice–Data Analytics for Optimal Detection of Metastatic Prostate Cancer;Operations Research;2021-05

2. Measuring Hospital-Acquired Complications Associated With Low-Value Care;JAMA Internal Medicine;2019-04-01

3. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer;BJU International;2018-02-16

4. A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer;Journal of Urology;2017-05